Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: J Clin Epidemiol. 2013 Aug;66(8 0):S99–S109. doi: 10.1016/j.jclinepi.2013.01.016

Table 1.

Crude and stabilized, truncated IPW estimates of the (cumulative) risk differences (RDs) for GFR worsening at 2 years. Each cell describes estimates of the risk difference between two exposure groups identified by the row and column labels. SE and p stand for standard error and p-value, respectively. The 95% confidence intervals are provided in parentheses next to the point estimates.

RD = row minus column met+sul sul met
no therapy crude −0.0524 (−0.0844; −0.0204)
SE=0.0163, p=0
0.0016 (−0.0271;0.0302)
SE=0.0146, p=0.91
−0.0088 (−0.0216;0.0039)
SE=0.0065, p=0.17
linear A1c 0.0406 (−0.0096;0.0907)
SE=0.0256, p=0.11
−0.0033 (−0.0371;0.0305)
SE=0.0172, p=0.85
−0.0137 (−0.0335;0.006)
SE=0.0101, p=0.17
non-linear A1c −0.1192 (−0.1962; −0.0423)
SE=0.0393, p=0
−0.009 (−0.0459;0.0279)
SE=0.0188, p=0.63
−0.0087 (−0.0287;0.0114)
SE=0.0102, p=0.4
super learning −0.0747 (−0.1451; −0.0044)
SE=0.0359, p=0.04
−0.016 (−0.0528;0.0208)
SE=0.0188, p=0.39
−0.0194 (−0.0419;0.003)
SE=0.0115, p=0.09

met crude −0.0436 (−0.0767; −0.0104)
SE=0.0169, p=0.01
0.0104 (−0.0195;0.0404)
SE=0.0153, p=0.5
linear A1c 0.0543 (0.0021;0.1066)
SE=0.0267, p=0.04
0.0105 (−0.0257;0.0467)
SE=0.0185, p=0.57
non-linear A1c −0.1105 (−0.1885; −0.0326)
SE=0.0397, p=0.01
−3e−04 (−0.0383;0.0377)
SE=0.0194, p=0.99
super learning −0.0553 (−0.1276;0.0171)
SE=0.0369, p=0.13
0.0034 (−0.0365;0.0433)
SE=0.0204, p=0.87

sul crude −0.054 (−0.0959; −0.0121)
SE=0.0214, p=0.01
linear A1c 0.0438 (−0.0151;0.1028)
SE=0.0301, p=0.15
non-linear A1c −0.1102 (−0.1939; −0.0266)
SE=0.0427, p=0.01
super learning −0.0587 (−0.1363;0.0188)
SE=0.0396, p=0.14